Home// - Novel mRNA vaccine candidate
Are you sure you want to exit?
Any unsave changes will be lost.
Novel mRNA vaccine candidate
eTheRNA Immunotherapies nv
Category
Laboratory
Country
Belgium, Europe
Description
eTheRNA Immunotherapies nv, a clinical-stage company developing vaccines and immunotherapies from its proprietary mRNA TriMix platform, today announced that a consortium has been formed with North American and European partners to develop a novel mRNA vaccine against CoV-2 and preclinical development has started. Chinese partners may be added in the consortium in due course.
Visit